• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

R9M:GR

0.065 EUR 0.001 1.52%

As of 13:55:04 ET on 11/21/2014.

Snapshot for Myrexis Inc (R9M)

Open: 0.044 Day's Range: 0.044 - 0.065 Volume: 0
Previous Close: 0.066 52wk Range: 0.044 - 0.185 1-Yr Rtn: +27.45%

Stock Chart for R9M

No chart data available.
  • R9M:GR 0.065
  • 1D
  • 1M
  • 1Y
0.066
Interactive R9M Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for R9M

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. DAX -
Earnings Per Share (ttm) -
Est. EPS -
Est. PEG Ratio -
Market Cap (M EUR) 2.24
Shares Outstanding (M) 34.48
30 Day Average Volume 219
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend (USD) 2.8600
Dividend Ex-Date 02/19/2013
5 Year Dividend Growth -
Next Earnings Announcement -
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for R9M

No data available

Company Profile & Key Executives for R9M

Myrexis Inc. is a biopharmaceutical company. The Company is focused on discovering, developing, and commercializing novel small molecule drugs for the treatment of cancer. Myriad's pipeline includes clinical and pre-clinical product candidates with distinct mechanisms of action and novel chemical structures.

Jonathan M CouchmanChairman/President/CEO/CFO
More Company Profile & Key Executives for R9M

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil